Skip to main content

Michaelson Jennifer's Form 4 filing

Cullinan Therapeutics, Inc. (CGEM) · filed May 8, 2024

Accession no.
0000950170-24-056093
Filed
May 8, 2024
Trade date
May 6-7, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.80M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Michaelson JenniferCIK 0001838061Officer (Chief Scientific Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 6, 2024Common StockMOption exerciseAcquired+50,000$4.30+$215,000187,582Direct
May 6, 2024Common StockSSaleDisposed−37,723$27.82−$1,049,453.86149,859Direct
May 6, 2024Common StockSSaleDisposed−20,277$28.54−$578,705.58129,582Direct
May 7, 2024Common StockMOption exerciseAcquired+5,606$4.30+$24,105.8135,188Direct
May 7, 2024Common StockSSaleDisposed−5,606$30.06−$168,516.36129,582Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 6, 2024Common StockMOption exerciseDisposed−50,000$0.00$0138,593Direct
May 7, 2024Common StockMOption exerciseDisposed−5,606$0.00$0132,987Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)